Bio-Rad

Dual‑Targeting Breakthroughs: Advancements in Bispecific Antibody Development

Download this complimentary Expert Insights eBook today!

Bio-Rad Acquires Stilla Technologies

Bio-Rad Laboratories, a life science research and clinical diagnostics company, has completed the acquisition of Stilla Technologies, a developer of digital PCR (dPCR) systems.

Top-Feature

SCIEX

Capillary Electrophoresis in Biotherapeutic Development: Platform Methods, Fragment Workflows, and ADC Characterization

Citrine

Operationalizing AI in Polymer Development: How Syensqo Is Scaling Impact with the Citrine Platform

CHEManager International c/o Wiley-VCH GmbH

Siemens Joins the Global Impact Coalition

Evonik Industries AG

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

Agilent Technologies Inc.

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Interview

Trade and Competitiveness

The CBA, led by CEO Tim Doggett, is steering the UK chemical supply chain through trade uncertainty, sustainability pressures and logistics challenges, as he explains in this interview with CHEManager.

Bio-Rad Laboratories

Bio-Rad

Dual‑Targeting Breakthroughs: Advancements in Bispecific Antibody Development

Bio-Rad Acquires Stilla Technologies

Top-Feature

Capillary Electrophoresis in Biotherapeutic Development: Platform Methods, Fragment Workflows, and ADC Characterization

Operationalizing AI in Polymer Development: How Syensqo Is Scaling Impact with the Citrine Platform

Upcoming Virtual Events

Siemens Joins the Global Impact Coalition

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Interview

The UK Chemical Supply Chain

Bio-Rad

Dual‑Targeting Breakthroughs: Advancements in Bispecific Antibody Development

Bio-Rad Acquires Stilla Technologies

Top-Feature

Capillary Electrophoresis in Biotherapeutic Development: Platform Methods, Fragment Workflows, and ADC Characterization

Operationalizing AI in Polymer Development: How Syensqo Is Scaling Impact with the Citrine Platform

Upcoming Virtual Events

Siemens Joins the Global Impact Coalition

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Interview

The UK Chemical Supply Chain

Newsletter & e-edition